AazeinTx announces new advisory board member Dr. Bill Brown

Published by AazeinTx on

AazeinTx is thrilled to announce the addition of their newest advisory board expert Dr. Bill Brown. He brings over 30 years of experience in the discovery and development of small molecule drugs, including the NEO6860 compound where he was a key inventor. This compound is at the foundation of AazeinTx’s revolutionary asthma treatment, which they’re currently working to move into Phase II trials.  

Dr. Brown is an accomplished drug discovery scientist, and has co-authored more than 30 peer-reviewed scientific publications, helped develop over 30 patents, and aided the advancement of seven compounds into phase II trials.  

“Bill’s deep expertise in drug discovery and translation make him a vital part of our advisory team,” said Lawrence Korngut, Chief Medical Officer at AazeinTx. “We are honoured to have him on board, and look forward to him aiding us in the development of our revolutionary treatment.” 

Click here to learn more.